![Mark Eccleston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Eccleston
Chief Executive Officer at
VALIRX PLC
Net worth: 171 187 $ as of 2026-07-30
Profile
Mark Edward Eccleston was the founder of Vivamer Ltd., founded in 2002, where the title held was Chief Scientific Officer from 2002 to 2006.
Dr. Eccleston is the founder of Volition, Inc., founded in 1997, holding the title Director-Business Development since 1997.
Current jobs include Chief Executive Officer & Director at ValiRx Plc starting in 2024, and Managing Director & Director at Oncolytika Ltd. starting in 2010.
Former jobs include Director at ADD Signs Ltd. from 2010 to 2017, and Chief Technology Officer at VolitionRX Ltd. from 2021 to 2024.
Education includes an MBA from the University Of Dundee conferred in 2008, and a doctorate from the University of Aston conferred in 1998.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VALIRX PLC 6.42% | 2026-05-19 | 84,746,187 ( 6.42% ) | 171 187 $ | 2026-07-30 |
Mark Eccleston active positions
| Companies | Position | Start |
|---|---|---|
| VALIRX PLC | Chief Executive Officer | 2024-08-11 |
Volition, Inc.
 Volition, Inc. Packaged SoftwareTechnology Services Develops software and games for PC computers | Founder | 1997-03-13 |
Oncolytika Ltd.
 Oncolytika Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an technical consultancy company providing research and development services in biotechnology | Chief Executive Officer | 2010-05-31 |
Former positions of Mark Eccleston
| Companies | Position | End |
|---|---|---|
| VOLITIONRX LIMITED | Chief Tech/Sci/R&D Officer | 2023-12-31 |
ADD Signs Ltd.
 ADD Signs Ltd. Miscellaneous ManufacturingProducer Manufacturing Designs and manufactures signs and provides sign fabrication & installation, vinyl graphics and printing services | Director/Board Member | 2017-02-02 |
Vivamer Ltd.
 Vivamer Ltd. BiotechnologyHealth Technology Manufactures drugs based on biopolymer chemistry | Chief Executive Officer | - |
Training of Mark Eccleston
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
ValiRx Plc
 ValiRx Plc Pharmaceuticals: MajorHealth Technology Develops novel technologies and products in oncology therapeutics and diagnostics | Health Technology |
Volition, Inc.
Volition, Inc. Packaged SoftwareTechnology Services Develops software and games for PC computers | Technology Services |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivamer Ltd.
Vivamer Ltd. BiotechnologyHealth Technology Manufactures drugs based on biopolymer chemistry | Health Technology |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
ADD Signs Ltd.
ADD Signs Ltd. Miscellaneous ManufacturingProducer Manufacturing Designs and manufactures signs and provides sign fabrication & installation, vinyl graphics and printing services | Producer Manufacturing |
Oncolytika Ltd.
Oncolytika Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as an technical consultancy company providing research and development services in biotechnology | Commercial Services |
- Stock Market
- Insiders
- Mark Eccleston
